Sunmax Biotechnology Co., Ltd.

4728

TW0004728001

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-05-14 EDT			5-day change	1st Jan Change
240 ^TWD	-1.03%		+4.12%	+17.65%

03-15	Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Sunmax Biotechnology Co., Ltd.(TPEX:4728) added to S&P Global BMI Index

September 19, 2022 at 12:00 am

Latest news about Sunmax Biotechnology Co., Ltd.

Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-15	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-12	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-14	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-13	CI
Sunmax Biotechnology Co., Ltd.(TPEX:4728) added to S&P Global BMI Index	22-09-19	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-14	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Half Year Ended June 30, 2021	21-08-15	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-12	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-12	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-12	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-03-29	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-12	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-13	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-14	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	19-03-21	CI
Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2018	18-11-11	CI

Chart Sunmax Biotechnology Co., Ltd.

Duration

Period

More charts

SunMax Biotechnology Co., Ltd. is a Taiwan-based company principally engaged in research, development, production and distribution of collagen implants and related products. The Company's major products include collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, as well as medical collagen application equipment. Its products are applied in medical and beauty care industrials. The Company distributes its products principally in Taiwan, Mainland China and other regions.

Sector

Biotechnology & Medical Research

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
SUNMAX BIOTECHNOLOGY CO., LTD.	+17.65%	408M
MODERNA, INC.	+28.87%	49.18B
IQVIA HOLDINGS INC.	+0.89%	42.11B
LONZA GROUP AG	+50.47%	40.37B
CELLTRION, INC.	-5.26%	28.85B
ICON PUBLIC LIMITED COMPANY	+13.30%	26.09B
ALNYLAM PHARMACEUTICALS, INC.	-22.53%	18.71B
BIO-TECHNE CORPORATION	+8.16%	13.26B
MEDPACE HOLDINGS, INC.	+32.17%	12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.45%	11.99B

Other Biotechnology & Medical Research